skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : ROSENFELD, JULIE BETH
Total Assignments: 3
Assignment: 1
Reel/Frame:013041/0264   Pages: 5
Recorded: 06/26/2002
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
Exec Dt:
05/23/2002
2
Exec Dt:
05/23/2002
Assignee
1
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
10113709
Correspondence name and address
MORRISON & FOERSTER LLP
CAROLYN A. FAVORITO
3811 VALLEY CENTRE DRIVE
SUITE 500
SAN DIEGO, CA 92130-2332
Assignment: 2
Reel/Frame:014198/0838   Pages: 5
Recorded: 06/24/2003
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
Exec Dt:
06/02/2003
2
Exec Dt:
06/16/2003
Assignee
1
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
NONE
10369022
Correspondence name and address
MILLENNIUM PHARMACEUTICALS, INC.
TRACY M. SIOUSSAT
75 SIDNEY STREET
CAMBRIDGE, MA 02139
Assignment: 3
Reel/Frame:017248/0601   Pages: 7
Recorded: 11/16/2005
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
Exec Dt:
10/19/2005
2
Exec Dt:
11/12/2005
Assignee
1
40 LANDSDOWNE STREET
CAMBRIDGE, MASSACHUSETTS 02139
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
NONE
11232776
Correspondence name and address
MARIO CLOUTIER
MILLENNIUM PHARMACEUTICALS, INC.
40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139

Search Results as of: 05/27/2024 12:58 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT